Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

The FDA has approved a supplemental biologics application for Leqembi Iqlik subcutaneous injection for maintenance dosing in ...

Onapgo, a subcutaneous apomorphine infusion device, is approved for advanced Parkinson's disease, offering continuous symptom management without surgery. The TOLEDO trial showed apomorphine infusion ...

The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of ...

The once-weekly subcutaneous autoinjector picked up an FDA approval late last week that clears the way for it to be an ...

The study results “highlight how even well-intentioned efforts to save patients’ time may face barriers,” the researchers wrote.